Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2012
02/02/2012WO2011081465A9 Pharmaceutical composition for suppression of vascularization
02/02/2012US20120030838 Novel fungal enzymes
02/02/2012US20120029091 Method of controlling the release of an active ingredient from a dosage form
02/02/2012US20120029084 Topical Nepafenac Formulations
02/02/2012US20120029081 Solid Pharmaceutical Compositions Containing Pregabalin
02/02/2012US20120029079 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
02/02/2012US20120029078 Compositions comprising myristic acid and uses thereof
02/02/2012US20120029053 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration
02/02/2012US20120029052 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration
02/02/2012US20120029051 siRNA Targeting VEGFA and Methods for Treatment In Vivo
02/02/2012US20120029034 Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/02/2012US20120029022 Potent Non-Urea Inhibitors Of Soluble Epoxide Hydrolase
02/02/2012US20120029019 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/02/2012US20120029016 Indoles Useful in the Treatment of Inflammation
02/02/2012US20120029008 Crystalline and amorphous forms of nalbuphine hydrochloride
02/02/2012US20120029007 Morphinan compounds
02/02/2012US20120029006 Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine Compounds
02/02/2012US20120028997 Prokineticin 1 receptor antagonists
02/02/2012US20120028995 Novel compounds for medical use as peptidase effectors
02/02/2012US20120028986 2-heteroaryl-pyrrolo [3,4-c]pyrrole derivatives, and use thereof as scd inhibitors
02/02/2012US20120028985 Combinational therapy for treating autoimmune disease
02/02/2012US20120028981 Kinase Knockdown Via Electrophilically Enhanced Inhibitors
02/02/2012US20120028980 Use of nk-1 receptor antagonists in management of visceral pain
02/02/2012US20120028977 Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions
02/02/2012US20120028974 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
02/02/2012US20120028968 Novel dibenzofuranyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
02/02/2012US20120028966 Protein kinase inhibitors
02/02/2012US20120028965 Compounds useful as protein kinase inhibitors
02/02/2012US20120028963 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
02/02/2012US20120028959 Dihydroorotate dehydrogenase inhibitors
02/02/2012US20120028958 5-alkynyl-pyrimidines
02/02/2012US20120028953 Azetidine Derivatives
02/02/2012US20120028952 5-alkynyl-pyrimidines
02/02/2012US20120028950 Substituted heterocyclylbenzylpyrazoles and use thereof
02/02/2012US20120028944 Cyclodextrin nanotechnology for ophthalmic drug delivery
02/02/2012US20120028943 Medicinal Cream Made Using Fluticasone Propionate And Chitosan And A Process To Make The Same
02/02/2012US20120028942 Medicinal Cream Made Using Neomycin Sulphate, Betamethasone Valerate, And Chitosan, And A Process To Make The Same
02/02/2012US20120028940 Functionally selective azanitrile alpha-2c adrenoreceptor agonists
02/02/2012US20120028939 Substituted naphthyridines and their use as medicaments
02/02/2012US20120028938 Pyrazole compounds as crth2 antagonists
02/02/2012US20120028937 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
02/02/2012US20120028929 Tetracycline stabilizing formulations
02/02/2012US20120028921 Methods and compositions using oxidized phospholipids
02/02/2012US20120028911 Mucin Derived Polypeptides
02/02/2012US20120028910 Storage-stable aqueous ophthalmic formulations
02/02/2012US20120028898 Methods for treatment of headaches by administration of oxytocin
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027875 Compositions for Treatment of Skin and Ear Infections
02/02/2012US20120027842 Topical formulations of flap inhibitors for administration to an eye
02/02/2012US20120027834 Methods of treatment with syk inhibitors
02/02/2012US20120027833 Drug-eluting films
02/02/2012US20120027816 Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
02/02/2012US20120027811 Formulations of Viable Cells for Oral Delivery
02/02/2012US20120027787 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
02/02/2012US20120027758 Use of anti-cd100 antibodies
02/02/2012US20120027756 Methods and compositions for treating allergic diseases
02/02/2012US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
02/02/2012US20120027742 Methods for treating adult respiratory distress syndrome
02/02/2012US20120027707 Lycogen extract, composition thereof and method for the treatment using the same
02/02/2012US20120027705 Administration of cells and cellular extracts for rejuvenation
02/02/2012US20120027701 Canna and Shea Topical Cream
02/02/2012US20120027697 Plant extracts, compositions containing same, and uses thereof
02/02/2012US20120027692 Pyrrolopyrimidinedione and its therapeutic use
02/02/2012US20120027691 Cinnamic Acid-Based Oligomers and Uses Thereof
02/02/2012US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method
02/02/2012US20120027680 Oxime conjugates and methods for their formation and use
02/02/2012US20120024743 Transdermal pharmaceutical preparations
02/02/2012CA2843265A1 Peripherally restricted faah inhibitors
02/02/2012CA2807097A1 Matrix metalloproteinase inhibitors
02/02/2012CA2806821A1 Fused ring pyridine compound
02/02/2012CA2806565A1 Hydrated sodium salt form of celecoxib
02/02/2012CA2804709A1 Immunogenic anti-inflammatory compositions
02/02/2012CA2804512A1 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions
02/01/2012EP2412719A1 Chi-conotoxin peptides
02/01/2012EP2412707A2 3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
02/01/2012EP2412372A1 2-Aminooxazole derivatives for use as TRPV1 antagonists for treating i.a. pain, inflammation, neurodegenerative diseases or gastrointestinal diseases
02/01/2012EP2412368A1 Method and composition for the treatment of scars
02/01/2012EP2411397A1 Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
02/01/2012EP2411396A2 Thienopyrimidinedione derivatives as trpa1 modulators
02/01/2012EP2411393A1 Fused pyrimidine-dione derivatives as trpa1 modulators
02/01/2012EP2411381A1 Substituted spiro-amide compounds
02/01/2012EP2410998A2 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
02/01/2012EP1934176B1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
02/01/2012EP1888595B1 Spiro-oxindole compounds and their uses as therapeutic agents
02/01/2012EP1848719B1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
02/01/2012EP1472353B1 Group b streptococcus antigen
02/01/2012EP1286989B1 Prodrug of an ICE inhibitor
02/01/2012CN1951899B 阿司匹林触发的脂质介体 Aspirin-triggered lipid mediators
02/01/2012CN102341400A Pyrrolopyrimidines used as kinase inhibitors
02/01/2012CN102341398A Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
02/01/2012CN102341395A 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents
02/01/2012CN102341394A Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
02/01/2012CN102341386A Pyridine derivative
02/01/2012CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase
02/01/2012CN102341384A P38 map kinase inhibitors
02/01/2012CN102341383A Inhibitors of Bruton's Tyrosine Kinase
02/01/2012CN102341371A Bis aromatic compounds for use as lct4 synthase inhibitors
02/01/2012CN102341124A External preparation containing analgesic/anti-inflammatory agent
02/01/2012CN102341123A External preparation containing analgesic/anti-inflammatory agent
02/01/2012CN102341122A External preparation containing analgesic/anti-inflammatory agent
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 1272